Synthetic biology has become a symbol of deeper questions about how science is governed.
In some European Union member states, there is significant uncertainty about whether existing bans on genetic engineering in embryos and germ line cells also prohibit basic research.
This report analyzes the future landscape of biotechnology products, and seeks to inform forthcoming policy making.
The US National Academies report presents conclusions about future biotechnology products and the anticipated challenges of regulating them.
The line between a research tool and a therapy is an important distinction to consider.
The American Society for Microbiology meeting on biological threats and emerging infectious diseases offered presentations on emerging bio-technologies including a synthetic biology panel.
A dog breeder planned to use the gene-editing technology CRISPR to alter dogs from a laboratory in a plywood shed.
UVA Today discusses the impact and potential regulation of gene editing technologies.
The International Biosecurity and Prevention Forum (IBPF) and the James Martin Center for Nonproliferation Studies (CNS) at the Middlebury Institute of International Studies at Monterey will be co-hosting the Symposium on Export Control of Emerging Biotechnologies.